Clinical Trials
39 trialsCAPT CTC
Institut Claudius Regaud
TARMAC
University College Hospital, Ibadan
PROBE-CTC
ScreenCell
Biomarkers to Detect Endocrine Therapy Resistance
University of Wisconsin, Madison
GALIA
Institute of Oncology Ljubljana
CTCNeoBC-E
RenJi Hospital
Sweden Cancerome Analysis Network - Breast Recurrence (SCAN-B-rec)
Lund University Hospital
ABC-SE
Lund University Hospital
Genomic Markers for Measuring Breast Cancer Response to Neoadjuvant Chemotherapy
Sunnybrook Health Sciences Centre
POSYTIVE
Austrian Breast & Colorectal Cancer Study Group
DETECT III
University of Ulm
DETECT IV - A Study in Patients With HER2-negative Metastatic Breast Cancer and Persisting HER2-negative Circulating Tumor Cells (CTCs).
University of Ulm
SCAN-B
Lund University
Digoxin Induced Dissolution of CTC Clusters
University Hospital, Basel, Switzerland
Early Detection of Breast Cancer
Datar Cancer Genetics Inc
HOMING
Angle plc
Establishment of a Tumor Bank for Blood Samples
Medical University of Vienna
CTCSFBC
Handan First Hospital
CTCs
Tomsk National Research Medical Center of the Russian Academy of Sciences
Circulating Tumor Cell Detection in Patients With Luminal A Breast Cancer
Shengjing Hospital
Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in Breast Cancer Patients
Hunan Cancer Hospital
Concordance Between Liquid and Tissue Biopsy
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
HER2Cell
AC Camargo Cancer Center
Plasma Circulating Tumor DNA Analyses in ER+ Metastatic Breast Cancer
UNC Lineberger Comprehensive Cancer Center
Detection of Circulating Tumor Cells in Breast Cancer Patients Using a Novel Microfluidic and Raman Spectrum Device
Xijing Hospital
Diagnostic Power Comparison Between VOCs and CTCs
Anhui Medical University
TREAT-CTC
European Organisation for Research and Treatment of Cancer - EORTC
Correlation Between Circulating Tumor Cells and Brain Disease Control After Focal Radiotherapy for Metastases of Breast Cancer
AC Camargo Cancer Center
Denosumab in Treating Patients With ER and/or PR Positive, HER2 Negative Metastatic Breast Cancer With Bone Metastases and Detectable Circulating Tumor Cells
Northwestern University
Medico-economic Interest of Taking Into Account Circulating Tumor Cells (CTC) to Determine the Kind of First Line Treatment for Metastatic, Hormone-receptors Positive, Breast Cancers
Institut Curie
COMETI P2
Janssen Diagnostics, LLC
Collection of Blood Specimens for Circulating Tumor Cell Analysis
Viatar LLC
The Detection of Circulating Tumor Cells (CTCs) in Patients With Breast Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment
Fuda Cancer Hospital, Guangzhou
ACABC
Zhejiang Provincial People's Hospital
Cultured Circulating Tumor Cells in Prostate and Other Cancers
Comprehensive Cancer Centers of Nevada
MACS1295
Novartis
CTC
Defense and Veterans Center for Integrative Pain Management
Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer
M.D. Anderson Cancer Center
Prospective Validation Trial of Circulating Tumor Cells (CTCs) in Women With Metastatic Breast Cancer
M.D. Anderson Cancer Center